Kringle Pharma, Inc.'s total assets for Q1 2025 were ¥2.54B, a decrease of -7.69% from the previous quarter. JP:4884 total liabilities were ¥645.61M for the fiscal quarter, a -0.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.